Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19-Reference-Cited by-同舟云学术

Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19

Published:2020-01 Issue:2 Volume:38 Page:173-179
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pebody Richard^ORCID,Whitaker Heather,Zhao Hongxin,Andrews Nick^ORCID,Ellis Joanna,Donati Matthew,Zambon Maria

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies;Belongia;Lancet Infect Dis,2016

2. Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17;Pebody;Euro Surveill,2018

3. Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015;Gilca;PLoS ONE,2015

4. Chapter 19: Influenza. Immunisation against Infectious Diseases [Internet]. Department of Health; [cited 2013 Nov 14]. p. 185–191. Available from: https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19.

5. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis;Domnich;Vaccine,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta‐analysis;Journal of the American Geriatrics Society;2024-09-04

2. End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain;Influenza and Other Respiratory Viruses;2024-05

3. Relative Effectiveness of the MF59®‐Adjuvanted Influenza Vaccine Versus High‐Dose and Non‐Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019–2020 US Influenza Season;Influenza and Other Respiratory Viruses;2024-04

4. Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults: A Review of Randomized Controlled Trials;Influenza and Other Respiratory Viruses;2024-04

5. Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients;Vaccine;2024-03